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Abstract
Background: Dietary fats and fructose have been responsible
for inducing obesity and body tissues damage due to the conse-
quence of metabolic syndrome through several mechanisms. The
body fat index (BFI) is one of the anthropometric measures used
to detect obesity in rats. This study aims to examine the correla-
tion between high-fat high-fructose diet and liver steatosis cell
count, early atherosclerosis characteristics, and body fat index
(BFI) in Sprague Dawley rats. 
Design and methods: This was an experimental design using
2 groups of 12-weeks-old Sprague Dawley (SD) rats. The control
group received a standard diet and tap water beverages for 17
weeks. The intervention group was fed with high-fat diet from
modified AIN 93-M and additional 30% fructose drink. We ana-
lyzed the foam cell count, aortic wall thickness, cardiac
histopathology, and liver steatosis cell count after the sacrifice
process. 
Results: The rats in the intervention group had a higher aortic
wall thickness, liver steatosis, and foam cell count (+125%,
p<0.01; +317%, p<0.01 and +165%, p<0.01 respectively) com-
pared to the control group. The intervention group also showed
higher mononuclear inflammatory and hypertrophic cell count. A
significant positive correlation was found between dietary fruc-
tose with premature atherosclerosis by increasing foam cell count
(r=0.66) and aortic wall thickness (r=0.68). In addition, 30%
dietary fructose increased liver steatosis (r=0.69) and mononu-
clear inflammatory cardiac cell count (r=0.61). Interestingly, the
intervention had no effect on the body fat index (p>0.5; r=0.13). 
Conclusions: Dietary fat and fructose consumption for 17
weeks promotes atherosclerosis, liver steatosis, and cardiac
histopathology alteration without increasing BFI.
Introduction
Obesity is the most important component of metabolic syn-
drome, as a result of imbalance between energy intake and expen-
diture, followed by an increase in adiposity. This condition is char-
acterized by the accumulation of visceral fat followed by certain
conditions, such as insulin resistance, lipid profile alteration, and
the elevation of chronic inflammation marker. Overweight and
obesity are among the risk factors in liver steatosis and atheroscle-
rosis, as well as structural and functional changes of the heart,
which cause heart failure.1-3 Atherosclerosis is known as chronic
inflammation disease leading to tunica intima thickening and arte-
rial rigidness, which starts with foam cell formation, atheroma,
leucocyte accumulation, smooth muscle proliferation, and, finally,
atherosclerosis formation.4 Liver steatosis, specifically non alco-
holic fatty liver disease, is a disease characterized by triglyceride
accumulation in the liver. It encompasses a variety of histopatho-
logical findings, from non-alcoholic steatohepatitis to fibrosis and
cirrhosis hepatic, which may develop into hepatocellular carcino-
ma.5 Meanwhile, obesity leads to heart failure through several
mechanisms, which includes hemodynamic changes and activa-
tion of the renin-angiotensin-aldosterone (RAAS) system. In addi-
tion, heart failure can be characterized by cardiac histopathology
alteration, which is promoted by platelet aggregation, endothelial
dysfunction, and interstitial cardiac.3
Overweight and obesity among Indonesian adults have gradu-
ally increased from 8.6% in 2007 to 13.6% in 2018 for overweight
and 10.5% in 2007 to 21.8% in 2018 for obesity. Central obesity
has also increased in adults, from 18.8% in 2007 to 31% in 2018.6
The WHO showed that overweight prevalence in adults reached
39% and 13% of adults were obese in 2016. Furthermore, 41 mil-
lion children under the age of 5 were obese or overweight and over
340 million children and adolescents were overweight or obese in
Significance for public health
Obesity is a major health problem that is a powerful inducer of non-communicable disease (NCD) both in the national and global level of the human popu-
lation age groups. Based on this study, consumption of fructose also poses an increased risk in developing metabolic syndrome, which differs from the current
understanding of dominantly caused by excessive intake of fat. Furthermore, high fructose consumption promotes early signs of cardiovascular and liver dis-
ease without significant manifestation in anthropometry characteristics. It is believed that these results are important and will give readers a broader view on
combating obesity epidemics from a dietary and nutritional perspective, which may also contain additional reference for nutrition education or dietary advice
for the prevention of obesity.
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2016.7 Obesity as well as other metabolic conditions such as high
blood pressure and high blood glucose were the key risk factors of
non-communicable disease (NCD). It is estimated that NCDs
account for 71% of the 57 million global deaths in productive age
(30-70 years old), which is consisted of 31% death caused by car-
diovascular disease and 3% death caused by diabetes.8
Several studies regarding obesity and excessive energy intake
were conducted.9-11 These conditions are linked to increased con-
sumption of high fat in fast-food and high fructose in soft drink.
Almost all types of soft-drink have some sorts of glucose or fruc-
tose content. Fructose is commonly used as a sweetener in these
beverages due to its sweet flavor, low cost, and ability to promote
a long shelf-life. Recent studies have also identified fructose as the
cause of obesity and other metabolic diseases.12,13 High fructose
intake is also linked to the increase of superoxide production,
which leads to endothelial damage.14
In connection with the recent trend of increased consumption
of soft-drinks and the used of fructose, there is a risk of excessive
consumption of fructose in relation to obesity, atherosclerosis,
liver steatosis, and the change in cardiac histopathology need fur-
ther investigation. This study examined the correlation between
high fructose diet and early atherosclerosis, which is characterized
by increased foam cell count, aortic wall thickness, liver steatosis
cell count, cardiac histopathology, and body fat index (BFI). More
specifically, this study systematically examined if high fat-high
fructose diet (HFFD) induced obesity first or body tissue damage
as the consequence of metabolic syndrome. Obesity was deter-
mined using anthropometric measurement, while body tissues
damage was determined by examine aortic wall thickness; foam
cell count; liver steatosis cell count; mononuclear inflammatory
cardiac cell count; and hypertrophic cardiac cell count.
Design and Methods
This research was experimentally designed, and all procedures
were approved by the research ethics committee of Faculty of
Medicine, Universitas Brawijaya, Indonesia
(368/EC/KEPK/10/2017). Thirty-six (36) male Sprague Dawley
(SD) obesity model rats aged 8 weeks were given four weeks
acclimatization period, which included one-rat-one-cage housing
and normal diet. The 36 rats were divided randomly into two
groups (n=18).15 The control group was fed normal or standard diet
containing 31% protein; 26% fat; and 43% carbohydrate. The other
group was fed with HFFD containing 52% fat; 22% protein; and
29% carbohydrate pellets with an addition of 30% fructose solu-
tion.16,17 The energy density was 4.21 kcal and 5.08 kcal for con-
trol group and HFFD group respectively. The dietary intervention
was carried out for 17 weeks (September 2017-January 2018). The
food, which was modified from AIN-93 M, was produced from
corn starch, dextrinized cornstarch, sucrose, soybean oil, casein,
egg-white flour, gelatin, mineral and vitamin mix AIN, L-cysteine,
and choline bitartrate. The composition of the two diets is shown
in Table 1.
Food intake, body weight gain, and body composition
The animals are weighed weekly during the 17 weeks interven-
tion period. Food consumption was calculated by weighing the
amount of total food (g) given to the rats and subtracting the
remaining food (g) in the cage every 24 h. After the intervention
period, rats were sacrificed by ketamine injection. We dissected
out and weighed the white adipose tissue (WAT), which is com-
prised of visceral fat (epididymal, perirenal, and omental fat) and
subcutaneous fat (inguinal fat). The BFI was determined as the
total amount of visceral and subcutaneous fat deposits per 100 g
body weight.18
Liver steatosis, aortic wall thickness, foam cell count,
and cardiac histopathology
Liver steatosis cell count was examined using Hematoxylin &
Eosin (HE) staining. Briefly, using a cryostat, the frozen rat livers
were placed in a 10 μm-portion cut and fixated in ice-cold 10% for-
malin. The livers were air dried for 60 min and rinsed 3 times in
distilled water. The slices were differentiated in 85% propylene
glycol solution for 5 min and stained in HE for 30 s. The specimens
were washed in running tap water for 3 min, mounted onto slides
using glycerin jelly, and covered.
Aortic wall samples were taken, rinsed in aquades, and fixed in
10% formalin for at least 7 hours. The aortic wall was sliced in 2-
3 mm sections and treating using Tissue Tex Processor for 90 min.
These tissues were treated for paraffin embedding, then sectioned
using microtome with 3-5 μ thin section and went in for deparaf-
finization process. The specimens were stained with standard HE
staining, and the wall thickness of the aorta was measured from the
tunica intima (TI) op to tunica media (TM) in 8 fields of view in a
clockwise direction (at 12.00; 13.30; 15.00; 16.30; 18.00; 19.30;
21.00; 22.30). For the foam cell count, the specimens were exam-
ined from all fields of view at the cross-section of the aortic wall.
The foam cells counted were those located in the tunica intima and
tunica media. The histological examinations were carried out at a
magnification of ×400 using a light microscope. In terms of car-
diac histopathology analysis, the variables examined were
mononuclear inflammatory heart count, hypertrophic heart count,
and fibrous formation. The major steps of histopathology sample
preparation were similar and included the process of paraffin
embedding followed by a deparaffinization process. The samples
for mononuclear inflammatory cell and hypertrophic cell examina-
tion were stained with standard HE staining and examined under
×400 and ×1000 magnification, while the fibrotic formation exam-
ination samples were stained using Masson Trichome staining and
examined under ×200 magnification.
Statistical analysis
Food intake, body weight gain, BFI, liver steatosis cell count,
aortic wall thickness, foam cell count, mononuclear inflammatory
cardiac cell count, and hypertrophic cardiac cell count were pre-
sented as mean and standard errors. BFI, total carbohydrate, and
protein intake data were transformed to log10 values and liver
steatosis, foam cell count data were converted to square root values
to achieve normality before further testing. Total carbohydrate
intake, protein intake, liver steatosis cell count, foam cell count,
and cardiac histology were analyzed using Mann-Whitney U test,
while the other comparison tests were analyzed using the inde-
pendent t-test. The differences are considered significant when p <
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Table 1. Composition of diet.
Component                             Group
                                                       Control group      HFFD group
Carbohydrate (%)                                                 42.87                           29.39
Protein (%)                                                            31.32                           21.81
Fat (%)                                                                    25.81                           51.64
Fructose (%)                                                             -                                  30
Energy density (kcal/g)                                        4.21                             5.08










0.05. Simple associations between energy and fat intake with
dependent variables were calculated using Pearson’s correlation
coefficient, while the association between total carbohydrate and
protein intake data and the dependent variables were calculated
using Spearman’s correlation coefficient. All of the statistical tests
were performed using SPSS Software (ver. 16.0, SPSS Inc.,
Chicago, IL, USA). 
Results and Discussions
The final examination was carried out on 14 rats in the control
group and 16 rats in HFFD group from 36 rats in the initial study
caused by death during the intervention.  The amount of food ener-
gy intake was significantly higher in HFFD group (+134%,
p=0.000). Rats on HFFD group had +127% higher fat intake and -
56% lower protein intake compared to rats in control group
(p=0.001 and p=0.000 for fat and protein intake respectively). Due
to the additional fructose solution in the HFFD group, the carbohy-
drate intake in the HFFD group was significantly higher (+ 208%,
p=0.000) than in the control group. We found no significant differ-
ence in the body weight gain between the two diet groups (Table
2). No difference in the body fat index was reported between con-
trol group and HFFD group. 
The number of liver steatosis cells was significantly higher in
the HFFD group (+ 317%; p=0.000) than in the control group. A
significantly greater aortic wall thickness and a significantly high-
er foam cell count in HFFD compared to control group was also
reported (Figure 1; +125%; p=0.000 and +165%; p=0.000 for aor-
tic wall thickness and foam cel,l respectively). The HFFD group
showed a higher mononuclear inflammatory cardiac cell count
(+120%, p=0.000) and hypertrophic cardiac cell count (+118%,
p=0.001). The presence of fibrotic cell was also observed in car-
diac histopathology examination of HFFD group (Figure 1).
The total energy intake was reported to be positively correlated
(Figure 2) with body fat index (R=0.366; p=0.047), body weight
gain (R=0.496; p=0.005), aortic wall thickness (R=0.708;
p=0.000), foam cell count (R=0.612; p=0.000), liver steatosis cell
count (R=0.650; p=0.000), and mononuclear inflammatory cardiac
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Table 2. Food intake, body weight gain, body fat index, liver steatosis, and cardiac histopathology of rats.
Variables                                           Group                                                                  Independent t-test
                                                                            Control (n=14)                            HFFD (n=16)                                                  
Energy intake (kcal/day)                                                               50.6 ± 6.8                                                  67.7 ± 6.4                                                                 0.000
Fat intake (g/day)                                                                            1.4 ± 0.2                                                    1.8 ± 0.3                                                                  0.001
Protein intake (g/day)                                                                    3.9 ± 0.5                                                    1.7 ± 0.3                                                                  0.000
Total carbohydrate intake (g/day)                                               5.4 ± 0.7                                                   11.3 ± 1.1                                                                 0.000
Body weight gain (g)                                                                    15.8 ± 23.7                                                31.3 ± 26.3                                                                  NS
Body fat index                                                                                27.4 ± 10.2                                                29.3 ± 12.9                                                                  NS
Liver steatosis cell count                                                            19.6 ± 20.0                                                62.2 ± 23.3                                                                0.000
Aortic wall thickness                                                                   103.6 ± 14.1                                               129.9 ± 6.6                                                                0.000
Foam cell count                                                                               3.3 ± 1.0                                                    5.4 ± 1.8                                                                  0.000
Mononuclear inflammatory cardiac cell count                        40.4 ± 4.1                                                  48.8 ± 5.0                                                                 0.000
Hypertrophic cardiac cell count                                             1527.3 ± 220.8                                          1812.8 ± 202.6                                                             0.001
Total cholesterol                                                                             51 ± 11.5                                                 61.8 ± 15.0                                                                0.038
Plasma Triglyceride                                                                       36.5 ± 11.2                                                40.2 ± 12.4                                                                  NS
Plasma HDL                                                                                     18.9 ± 4.7                                                  23.3 ± 7.8                                                                   NS
Plasma LDL                                                                                      24.7 ± 8.0                                                  30.2 ± 8.3                                                                   NS
Values are means ±SEM, n=30; HFFD, high-fat fructose diet; HDL, high density lipoprotein; LDL, low density lipoprotein; NS, not significant.
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Figure 1. The effect of HFFD on thickness of aorta tissues and
foam cell count of Sprague Dawley Rats. A) Aorta tissues of con-
trol diet. B) Aorta tissues of HFFD. C) Foam cell of control diet.
D) Foam cell of HFFD. E) Mononuclear inflammatory cardiac
cell of control diet. F) Mononuclear inflammatory cardiac cell of
HFFD. G) Hypertrophic cardiac cell of control diet. H)
Hypertrophic cardiac cell of HFFD. I) Absence of fibrotic forma-
tion in cardiac cell of control diet group. J) Fibrotic formation in










cell count (R=0.529; p=0.003). There was a positive association
(Figure 3) between fat intake and body fat index (R=0.576;
p=0.001), body weight gain (R=0.652; p=0.000), aortic wall thick-
ness (R=0.550; p=0.002), foam cell count (R=0.521; p=0.003), and
liver steatosis cell count (R=0.579; p=0.001). The total carbohy-
drate intake including carbohydrate from food and fructose from
drink also showed a positive association (Figure 4) with body
weight gain (R=0.410; p=0.024), aortic wall thickness (R=0.767;
p=0.000), foam cell count (R=0.657; p=0.000), liver steatosis cell
count (R=0.657; p=0.000), and mononuclear inflammatory cardiac
cell count (R=0.613; p=0.000), although there was no statistical
association between total carbohydrate intake and body fat index
and hypertrophic cardiac cell count. 
The protein intake showed no statistical association with body
fat index and body weight gain, although it was negatively associ-
ated with aortic wall thickness (R= −0.622; p=0.000), foam cell
count (R=−0.503; p=0.005), liver steatosis cell count (R= −0.628;
p=0.000), mononuclear inflammatory cardiac cell count (R=
−0.586; p=0.001), and hypertrophic cardiac cell count (R= −0.512;
p=0.004). This study showed no difference in body weight gain
(BWG) and BFI between the two groups. This is in line with the
studies conducted by Ble-Castillo et al., and Pang et al., which
reported that BWG is was not significantly higher in rats adminis-
tered with high-fat and high-fructose diet than in the control
group.19,20 Despite the lack of significant differences in BWG and
BFI after HFFD treatment, this study showed that energy and fat
intake were associated with increase in BWG and BFI while fruc-
tose intake was only positively correlated with BWG. This is sim-
ilar to the results of previous studies that showed that higher levels
of energy and fat in HFFD promoted obesity, which is character-
ized by higher fat mass, visceral fat, and body fat percentage.13,21,22
Several previous studies also claim that higher energy, fat, and
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Figure 2. Significant correlations were found between energy
intake and (A) body weight gain; B) body fat index; C) aorta
thickness; D) foam cell number; E) liver steatosis; F) mononu-
clear inflammatory cardiac cell count.
Figure 3. Significant correlations were found between fat intake
and (A) body weight gain; B) body fat index; C) aorta thickness;
D) foam cell number; E) liver steatosis.
Figure 4. Significant correlations were found between carbohy-
drate intake and  (A) body weight gain; (B) aorta thickness; (C)
foam cell number; (D) liver steatosis; (E) mononuclear inflamma-
tory cardiac cell number.
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fructose intake not only promote 1.3-1.4× higher BWG increase
than the normal group but also increased body fat.13,20,21
Several factors that can explain these different results are diet
composition and duration of intervention. In this study, HFFD con-
taining 51% fat and 30% fructose drink administered during a 17-
week period produced no different effect on BFI and BWG.
Similar result is also demonstrated by another study using 60% fat
and 20% of glucose addition for 12 weeks. Meanwhile, other stud-
ies  using a variety of fat and fructose composition such as  45%
fat for 35 weeks, 15% fructose for 24 weeks, and high-fat and
sucrose intervention for 60 weeks promoted BWG and body fat
increase.13,21,22 Some high-fat diet (45% fat or 60% fat) increased
20-30% body weight after a feeding period of 16-20 weeks, while
the manifested picture of obesity such as increased fat mass started
to develop after 16 weeks.23 However, fructose is more likely to
cause body weight gains if consumed over a long period of time.
Furthermore, it was known that HFFD had no adverse effects on
glucose and fat metabolism compared to a high-fat diet alone,
while high-saturated fat diet might have more significant effect on
body weight gain although having  similar calorie content.20
Therefore, the duration of intervention, macronutrient ratio, and
fructose drink ratio are also important both for body weight and
body fat gain.
The histological examination of the liver showed that the
HFFD group had a significantly higher liver steatosis count than
the normal diet group. Statistical analysis showed that there was a
positive association between energy, fat, and fructose intake and
liver steatosis cell count, while protein intake was negatively asso-
ciated with liver steatosis. This finding is in line with previous
studies that indicated that consumption of fructose and fat pro-
duced larger droplets of liver lipids and promoted increased liver
fat.20,22 Furthermore, protein intake plays a role in improving liver
steatosis, which is essential in the regeneration of hepatocytes and
provides important amino acids that prevent liver fat deposition.
This is demonstrated by studies using mung bean protein to reduce
hepatic triglyceride concentration in 4 weeks.24,25 However, anoth-
er study showed different finding in which higher total liver fat ele-
vation occurred in rats given high-unsaturated fat diet than rats
given high-saturated fat diet, which also means that high carbohy-
drate intake is also needed to affect metabolic control.19
This imbalance in macronutrient absorption can affect nutrient
synthesis, degradation, and liver secretion in the liver that can
induce liver fat accumulation, which results in liver steatosis and
inflammation that lead to cardiovascular disease. The addition of
fructose to drinking water may lead to the formation of triglyceride
and VLDL via de novo lipogenesis in the liver by causing liver
steatosis.  Another mechanism by which fructose causes fatty liver
disease is mediated by GLUT2, which transports fructose in the
hepatocytes, which then undergoes phosphorylation into fructose-
1-phosphate by fructokinase and is split into glyceraldehyde and
dihydroxyacetone phosphate by hepatic aldose. Both compounds
can be converted into acetyl-CoA and enter the respiratory system
to produce ATP or move as glycerol to produce triglyceride.
Therefore, long-term fructose consumption may lead to metabolic
impairment due to an increase in TG and accumulation of hepatic
fat.5,26,27 This study also reported that aortic wall thickness and
foam cell count were significantly higher in HFFD than normal
diet group. Protein intake is negatively associated with the 2
parameters, and the higher the energy, fat, and fructose intake, the
higher the foam cell count and aortic wall thickness. This finding
is in line with a previous study conducted in rats, which were given
a high-fat diet for 6 months. At the end of the intervention, exam-
ination showed that the thickness of aorta rose in high-fat diet and
that this increase was followed by endothelial damage in the form
of alteration of endothelial lining and edema formation.28 Other
studies also showed that high-fructose or high-fat diet given for 8
weeks resulted in the thickening of abdominal aortic in 32 Sprague
Dawley rats and increased aorta lesion by 40% higher than the con-
trol group of 29 WHHL/Watanabe Heritable Hyperlipidemic rab-
bits.11,29 HFFD can also lead to the alteration of lipid serum, which
is significantly associated with aorta thickening. This mechanism
is stimulated by the rising of macrophage and smooth muscle cell
resulting in aorta lesion and pathologic intimal thickening that lead
into atherosclerosis plaque.1,11,29 Foam cell formation is mainly
influenced by advanced glycation end products (AGE), which are
formed endogenously through food due to the high intake of sug-
ars, including fructose. Furthermore, AGE is also one of the factors
responsible for diabetic nephropathy, which is associated with lipid
accumulation. Carboxymethyl lysine as a member of AGEs
increases lipid uptake and synthesis, and promote foam cell forma-
tion through increasing transcription and protein glycosylation of
cleavage-activating protein in human mesangial cells.30 High-fat
with fructose addition might have stronger effect on foam cell for-
mation than high-fat alone. This is related with high expression of
CCR7 (M1-phenotype) in advanced lesions located in the fibrous
cap-like sites and M2-macrophages expressed abundantly in the
foam-cell cores.31
Instead of using plant-based proteins such as soybeans, casein
was used as a source of protein in this study because of its hyper-
cholesterol-lowering effects as well as its effect on the formation
of atherosclerotic lesions. In addition, it was reported that casein
intake had a negative association with formation of atherosclerotic
lesion (r= -0.503). However, another study, which compared soy-
bean and casein as protein source showed that casein had a higher
probability of promoting atherosclerotic lesion formation.
Therefore, the association between total casein intake and the
occurrence of atherosclerosis is inconclusive.32,33
The histological examination of the heart showed higher val-
ues for inflammatory mononuclear and hypertrophic heart cells in
the HFFD group, although there was no correlation between the
intake of fat and fructose and the histological parameters of the
heart. However, HFFD group clearly exhibited fibrotic presence
and hypertrophic cell condition, which was also showed in some
previous studies.14,34 This histology alteration is a manifestation of
chronic inflammation, which starts from the inside of myocardium
as the adaptive response, then causes activation of free radicals and
chronic inflammation including cell hypertrophy. The chronic
inflammation increases the production of TNF-α, which induces
the release of IL-6 that leads to cell hypertrophy and also infiltra-
tion of the mononuclear cell. The formation of fibrosis also occurs
in this state, starting from the increase of collagen from cardiac
fibroblast as a result of chronic inflammation. Myocardial hyper-
trophy as a result of a high-fructose diet is caused by increased
mitochondrial oxidative stress. This oxidative stress is stimulated
by the decrease of cystic fibrosis transmembrane conductance reg-
ulator (CFTR) as the effect of a high-fructose diet.35,36
This study showed that protein intake was negatively associat-
ed with aorta thickness and cardiac histology parameter. However,
the literature review shows mixed results, and another study
observed that higher vegetable protein intake was linked to lower
risk of coronary heart disease. While another study showed that
animal-protein intake, with respect to its saturated fatty acid and
cholesterol content, can increase mortality risk of cardiovascular
diseases. This study, however, did not assess specifically the effect
of different protein intake, and the difference results from variation
in the composition of normal diet and HFFD feeding and feeding
ingredients. The high-fat group can develop cardiac muscle injury
caused by high oxidative stress, which also leads to lipotoxicity










and abnormality in left ventricle contraction. Fibrosis occurs due to
the increased infiltration of inflammatory cells to myocardium and
upregulation of pro-inflammatory cytokines (IL-1β and TNF-α)
and adhesion molecules such (ICAM1 and VCAM).14,37,38
Global sugar consumption, including fructose, has been
increasing over the past few decades along with the rise in Gross
National Product (GNP) and urbanization. In addition, urbaniza-
tion itself is  highly correlated with easy access to processed food,
which has high sugar content, as well as access to mass media,
mass transportation, and modern market.39 In Indonesia, many sur-
veys showed that the average sugar consumption per capital was
46 g/day. This is much higher than the national recommendation of
<25 g/day but is slightly lower than WHO recommendation of 50
g/day. Most sugars consumed were crystalized sugar, brown sugar,
sweetened condensed milk, syrup, sweetened drink, and traditional
snack.40 In general, fructose consumption poses higher risk of obe-
sity than sucrose as it is more easily absorbed in the intestine. In
addition, as its main metabolism occurs in the liver, fructose can be
easily changed into to fructose-1 phosphate, which is the precursor
for triglyceride (TG) formation. Moreover, fructose can also be
broken down into carbon molecules before reaching phosphofruc-
tokinase form. This molecules can transform into glycerol and
fatty acid that lead to adiposity.9
Consuming fructose poses a greater risk of developing meta-
bolic syndrome than consuming other sugars because fructose has
a different intermediate metabolism in which fructose can be more
easily removed from the plasma and then gets to the liver without
insulin being metabolized. Although the metabolism of glucose via
hexokinase and glycolysis is regulated by the energy state and the
level of insulin in the cell, the metabolism of fructose does not
require such regulations. It is broken down easily into glycolytic
phase and then go to lipogenesis one. Fructose and sucrose content
in the drink may have a higher effect on lipid serum than glucose.12
Therefore, it is important to limit fructose intake in relation to
metabolic syndrome risk, and its restriction is known to decrease
blood pressure, which may improve heart rate and cardiac output.
Fructose restriction can also repair insulin sensitivity and glucose
tolerance, although it is not directly related to body weight
change.41
Conclusions
This study showed that HFFD had no difference in body
weight gain and body fat index. Meanwhile, there was higher liver
steatosis cell count, greater aortic wall thickness, higher foam cell
count, and the presence of fibrotic in the cardiac cell. This research
showed that high fructose consumption may promote early signs of
cardiac disease characterized by atherosclerosis signed by cardiac
histopathology deterioration and increase of foam cell and aorta
thickness. Furthermore, HFFD consumption may stimulate liver
steatosis without the occurrence of obesity as indicated by anthro-
pometry measurement. This study encourages further exploration
of the HFFD effect in relation to other metabolic changes such as
plasma lipid profile or the composition of gut microbiota.
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